Related Experiment Video
Updated: Jun 19, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Intestinal microbial and metabolite profile in infants with small bowel stomas after bowel resection
Hannah G Piper1, Michael Bording-Jorgensen2, Simona Veniamin2
1Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Infants with small bowel stomas have unique gut bacteria and metabolic by-products in their stoma effluent. These differences correlate with poor growth and enteral tolerance, impacting nutrient absorption.
Area of Science:
- Neonatal surgery
- Gastroenterology
- Microbiome research
Background:
- Infants with small bowel stomas (SBstoma) often experience malabsorption and require parenteral nutrition (PN).
- Predicting intestinal absorption solely on anatomy is challenging.
- This study investigated stoma effluent microbiota and metabolites to understand absorption.
Purpose of the Study:
- Characterize the gut bacteriome and metabolic by-products in stoma effluent.
- Correlate these findings with clinical features and intestinal absorption.
- Identify biomarkers for predicting outcomes in infants with SBstoma.
Main Methods:
- Prospective cohort study of neonates with SBstoma (N=23) and colostomy controls (N=6).
- Collected stoma samples for 16S rRNA sequencing (bacteriome), short-chain fatty acids (SCFAs), and bile acids (BAs).
- Assessed fluid and energy loss, correlating with bowel length, PN dependence, and growth.
Main Results:
- Infants with ≤50% small bowel lost more fluid but had similar energy losses compared to controls.
- Poorly growing infants showed an enrichment of Proteobacteria in their gut bacteriome.
- Increased secondary bile acids correlated with poor prognostic factors like short bowel length and high PN dependence.
Conclusions:
- Infants with SBstoma and poor growth exhibit distinct bacteriome communities.
- Metabolic differences in stoma effluent are associated with poor enteral tolerance.
- Microbiota and metabolite analysis offers insights into absorption and growth in neonates with SBstoma.
Background:
Infants with small bowel stomas (SBstoma) frequently struggle with absorption and rely on parenteral nutrition (PN). Intestinal absorption is difficult to predict based solely on intestinal anatomy. The purpose of this study was to characterize the microbiota and metabolic by-products within stoma effluent and correlate with clinical features and intestinal absorption.
Methods:
Prospective cohort study collecting stoma samples from neonates with SBstoma (N = 23) or colostomy control (N = 6) at initial enteral feed (first sample) and before stoma closure (last sample). Gut bacteriome (16S ribosomal RNA [rRNA] sequencing), short-chain fatty acids (SCFAs) and bile acids (BAs) were characterized along with volume and energy content of a 48 h collection via bomb calorimetry (last sample). Hierarchical clustering and linear regression were used to compare the bacteriome and BAs/SCFAs, to bowel length, PN, and growth.
Results:
Infants with ≤50% small bowel lost more fluid on average than those with >50% and controls (22, 18, 16 mL/kg/day, p = 0.013), but had similar energy losses (7, 10, 9 kcal/kg/day, p = 0.147). Infants growing poorly had enrichment of Proteobacteria compared to infants growing well (90% vs. 15%, p = 0.004). An increase in the ratio of secondary BAs within the small bowel over time, correlated with poor prognostic factors (≤50% small bowel, >50% of calories from PN, and poor growth).
Conclusion:
Infants with SBstoma and poor growth have a unique bacteriome community and those with poor enteral tolerance have metabolic differences compared to infants with improved absorption.
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

